021-51111890
购物车（）
sales@molnova.cn
Olcegepant (hydrochloride)
CAS No. 586368-06-1
Olcegepant (hydrochloride) ( BIBN-4096 hydrochloride;BIBN-4096BS hydrochloride )
产品货号. M15157 CAS No. 586368-06-1
The first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ￥6585 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Olcegepant (hydrochloride)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述The first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP.
-
产品描述The first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP; inhibits the effects of CGRP, released by stimulation of the trigeminal ganglion, on facial blood flow in marmoset monkeys (1-30mg/kg, i.v.).
-
同义词BIBN-4096 hydrochloride;BIBN-4096BS hydrochloride
-
通路GPCR/G Protein
-
靶点CGRP Receptor
-
受体CGRP Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number586368-06-1
-
分子量906.11
-
分子式C38H47Br2N9O5.HCl
-
纯度>98% (HPLC)
-
溶解度H2O: ≥ 66.66 mg/mL
-
SMILESC1CN(CCC1N2CC3=CC=CC=C3NC2=O)C(=O)NC(CC4=CC(=C(C(=C4)Br)O)Br)C(=O)NC(CCCCN)C(=O)N5CCN(CC5)C6=CC=NC=C6.Cl
-
化学全称1-Piperidinecarboxamide, N-[(1R)-2-[[(1S)-5-amino-1-[[4-(4-pyridinyl)-1-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-, hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Doods H, et al. Br J Pharmacol. 2000 Feb;129(3):420-3.
2. Powell KJ, et al. Br J Pharmacol. 2000 Nov;131(5):875-84.
3. Edvinsson L, et al. Eur J Pharmacol. 2002 Jan 2;434(1-2):49-53.
2. Powell KJ, et al. Br J Pharmacol. 2000 Nov;131(5):875-84.
3. Edvinsson L, et al. Eur J Pharmacol. 2002 Jan 2;434(1-2):49-53.
产品手册
关联产品
-
MK-3207 (Hydrochlori...
A highly potent, selective CGRP receptor antagonist with Ki of 21 pM in in vitro binding assay and IC50 of 0.12 nM in cell-based functional assay.
-
Calcitonin salmon
Calcitonin salmon, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
-
α-CGRP (human)
Endogenous calcitonin gene-related peptide receptor (CGRP) agonist.
